News and Updates

On Sunday, December 8—also known as Week  14 for NFL fans—the NFL’s My Cause, My Cleats campaign returned for the fourth consecutive season. This campaign allows players to express their commitment and promote the causes that are most important to them. Throughout the campaign, players represent hundreds of charitable organizations that focus on causes such […]

As the leading global funder of type 1 diabetes (T1D) research, Breakthrough T1D invests in the most promising research studies across the world—including more than 70 clinical trials happening right now—to help improve the lives of people with T1D and find cures. That’s a big deal! Let’s take a look at three of them: A […]

Breakthrough T1D is funding work to build a better insulin infusion set; the current infusion sets can be uncomfortable and unreliable, and need to be changed every two to three days. One partner is Pacific Diabetes Technologies, who will test its all-in-one continuous glucose monitoring (CGM) sensor and infusion set in people with type 1 […]

Reza Abdi, M.D., has a reason to care about type 1 diabetes research—he has a father and a brother with the disease. Dr. Abdi, of Brigham and Women’s Hospital in Boston, is an expert in immune therapy research, specifically nanotechnologies—miniscule therapies that can deliver immune treatments to specific regions in the body. His goal: To […]

We’ve spent the past month celebrating the many type 1 diabetes (T1D) champions in our community. From all of the resilient people living with T1D, to the parents and other family members who are so supportive, to the coaches, teachers, and classmates dedicated to making a safe and welcoming environment, to all of the powerhouse donors, volunteers, and advocates who are making a […]

Last week’s Breakthrough T1D Beta Cell Replacement Consortium enabled 57 researchers the chance to collaborate in ways that help move research forward more quickly and efficiently. This crucial network helps scientists join forces to address gaps in research, complete clinical translation, and solve technical and operational challenges to accelerate life-changing therapies for people living with […]

Sernova, a clinical-stage regenerative medicine company, has shown in its Breakthrough T1D-funded clinical trial that its cell replacement therapy, the Cell Pouch System™, can produce insulin in people with type 1 diabetes (T1D). The technology consists of a dose of purified islet cells transplanted into the Cell Pouch™. The detection of C-peptide, a biomarker of […]

By Aaron J. Kowalski, Ph.D.President and CEO, Breakthrough T1D I don’t remember a time when type 1 diabetes (T1D) was not part of my family’s life. When I was six, my brother Steve was diagnosed, and when I was 13, I was too. Recently, at a gathering of staff and volunteer leaders from across the […]

Among more than a million supporters, they stand out. Four volunteers who have made a lasting, positive impact on Breakthrough T1D and the type 1 diabetes (T1D) community. For their work, their dedication and commitment, Breakthrough T1D is honoring them with awards of recognition and thanks. “We are grateful to every single one of our […]

Are you a college-aged student with type 1 diabetes (T1D) looking for an exciting opportunity to grow your professional network, expand your career ambitions and gain new experiences? Are you looking to contribute to the advancement of breakthroughs in T1D research, advocacy, and management? Breakthrough T1D’s College Internship Program is for you! The program is […]